EHA Guidelines

3.7K installs
Ratings not yet available
403 monthly active users
Revenue not available
Install Trends
Weekly +198
Steady
Monthly +232
Steady

EHA Guidelines Summary

EHA Guidelines is a mobile Android app in Medical by European Hematology Association. Released in Jun 2023 (2 years ago). It has about 3.7K+ installs Based on AppGoblin estimates, it reaches roughly 403 monthly active users . Store metadata: updated Apr 28, 2025.

Recent activity: 198 installs this week (232 over 4 weeks) showing steady growth View trends →

Store info: Last updated on Google Play on Apr 28, 2025 .


0★

Ratings: 0

5★
4★
3★
2★
1★

Screenshots

App screenshot
App screenshot
App screenshot
App screenshot

App Description

EHA's clinical practice guidelines, interactive tools and algorithms, and more

The EHA Guidelines app is a free service offered by the European Hematology Association. The app contains hematology clinical practice guidelines, interactive tools, diagnostic algorithms, calculators, and more.

The initial release features four pilot guidelines with full implementation of tools and interactivity, along with more guideline PDFs. Interactive versions of these guidelines are coming soon.

App features:
- Interactive guidelines for easy navigation
- Full-text guidelines or direct link to guidelines
- Interactive algorithms and tools
- Add notes and bookmark important pages
- Print or share important content or interactive pages

For more information please contact us at guidelinesapp@ehaweb.org

Note:
These guidelines reflect the current state of scientific research and have been compiled with careful consideration of evidence-based criteria. Doctors are advised to fully incorporate these guidelines into their clinical judgment. However, the editor, authors, and software developer cannot guarantee the completeness, accuracy, correctness, and timeliness of the contents. Each user is requested to check the information provided in this app in each individual case and to act on their own responsibility. Any diagnosis, therapy, dosage, or application is at the user’s own risk.